|
DE2931398A1
(de)
*
|
1979-08-02 |
1981-02-26 |
Kali Chemie Pharma Gmbh |
Neue 1-benzoxepin-5(2h)-on-derivate und ihre salze, verfahren und zwischenprodukte zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE2931399A1
(de)
*
|
1979-08-02 |
1981-02-26 |
Kali Chemie Pharma Gmbh |
Neue 3-amino-1-benzoxepin-derivate und ihre salze, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
|
NZ207110A
(en)
*
|
1983-02-15 |
1986-05-09 |
Merrell Dow Pharma |
(4a,11b)-3,4,4a,5,6,11b-hexahydro-2h-(1)benzoxepino(5,4,b)-1,4-oxazine derivatives and pharmaceutical compositions
|
|
PH21961A
(en)
*
|
1983-02-15 |
1988-04-15 |
Merrell Dow Pharma |
2h-(1)benzoxepino(5,4-b)-1,4-oxazine derivative
|
|
DE3440296A1
(de)
*
|
1984-11-05 |
1986-05-15 |
Kali-Chemie Pharma Gmbh, 3000 Hannover |
3-amino-2,3-dihydro-1-benzoxepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
US4975461A
(en)
*
|
1986-06-19 |
1990-12-04 |
E. R. Squibb & Sons, Inc. |
P-aminophenols, derivatives thereof and method of use
|
|
AU597671B2
(en)
*
|
1986-06-20 |
1990-06-07 |
Suntory Limited |
2-Phenylbenzoxepin derivative
|
|
FR2698873B1
(fr)
*
|
1992-12-07 |
1995-02-24 |
Lipha |
Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
|
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US5994391A
(en)
*
|
1994-09-13 |
1999-11-30 |
G.D. Searle And Company |
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
|
US6107494A
(en)
*
|
1994-09-13 |
2000-08-22 |
G.D. Searle And Company |
Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
|
EP0781278B1
(en)
*
|
1994-09-13 |
2001-03-14 |
Monsanto Company |
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
EP1440972A1
(en)
*
|
1996-03-11 |
2004-07-28 |
G.D. Searle & Co. |
Novel benzothiepines having pharmaceutical activity.
|
|
BR9708042A
(pt)
*
|
1996-03-11 |
1999-07-27 |
Searle & Co |
Novas benzotiepinas tendo atividade como inibidores de transporte de ácido de bile ileal e de absorção de taurocolato
|
|
EP0888333B1
(en)
*
|
1996-03-11 |
2005-08-31 |
G.D. Searle LLC |
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
|
PT1140188E
(pt)
|
1998-12-23 |
2003-10-31 |
Searle Llc |
Combinacoes de inibidores do transporte de acidos biliares do ileo e de inibidores da proteina de transferencia de esteres de colesterilo para doencas cardiovasculares.
|
|
ATE242007T1
(de)
|
1998-12-23 |
2003-06-15 |
Searle Llc |
Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen
|
|
HK1045114A1
(zh)
|
1998-12-23 |
2002-11-15 |
G‧D‧瑟尔有限公司 |
适用於心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合
|
|
CZ20012341A3
(cs)
|
1998-12-23 |
2001-12-12 |
G. D. Searle Llc Corparate Patent Department |
Kombinace inhibitorů transferoního proteinu cholesterylesterů a derivátů kyseliny fibrové pro kardiovaskulární indikace
|
|
WO2000038722A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
|
|
BR9916484A
(pt)
|
1998-12-23 |
2002-01-22 |
Searle Llc |
Combinações de inibidores do transporte de ácido biliar ileal e de agentes sequestrantes de ácido biliar em indicações cardiovasculares
|
|
EP1340510A1
(en)
|
1998-12-23 |
2003-09-03 |
G.D. Searle LLC. |
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
|
|
AU2001240115A1
(en)
|
2000-03-10 |
2001-09-24 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
|
CA2464685A1
(en)
|
2001-11-02 |
2003-05-15 |
G.D. Searle Llc |
Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
|
|
AU2003207431A1
(en)
|
2002-01-17 |
2003-09-02 |
Pharmacia Corporation |
Novel alkyl/aryl hydroxy or keto thiepines.
|
|
WO2013063526A1
(en)
|
2011-10-28 |
2013-05-02 |
Lumena Pharmaceuticals, Inc. |
Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
|
|
EA030839B1
(ru)
|
2011-10-28 |
2018-10-31 |
ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи |
Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
|